SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-24-148846
Filing Date
2024-05-29
Accepted
2024-05-29 11:55:50
Documents
2
Group Members
ALBERT CHADANIEL ESTESFHMLS X, L.L.CFHMLS X, L.PFHMLS XI, L.L.CFHMLS XI, L.PFHMLSP OVERAGE, L.L.CFHMLSP OVERAGE, L.PFHMLSP, L.L.CFHMLSP, L.PFRAZIER LIFE SCIENCES PUBLIC OVERAGE FUND, L.PFRAZIER LIFE SCIENCES X, L.PFRAZIER LIFE SCIENCES XI, L.PJAMES BRUSHJ

Document Format Files

Seq Description Document Type Size
1 SC 13G d756326dsc13g.htm SC 13G 303857
2 EX-99.A d756326dex99a.htm EX-99.A 27618
  Complete submission text file 0001193125-24-148846.txt   333639
Mailing Address 10835 ROAD TO THE CURE, SUITE 140 SAN DIEGO CA 92121
Business Address 10835 ROAD TO THE CURE, SUITE 140 SAN DIEGO CA 92121 (858) 465-6511
Erasca, Inc. (Subject) CIK: 0001761918 (see all company filings)

IRS No.: 831217027 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92728 | Film No.: 24995837
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1001 PAGE MILL ROAD BUILDING 4, SUITE B PALO ALTO CA 94304
Business Address 1001 PAGE MILL ROAD BUILDING 4, SUITE B PALO ALTO CA 94304 650-325-5156
Frazier Life Sciences Public Fund, L.P. (Filed by) CIK: 0001863769 (see all company filings)

IRS No.: 862999645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G